PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Itaconate modifications: mechanisms and applications

Study uncovers dual roles of itaconate in controlling immune pathways, highlighting its potential for treating infection and inflammatory disorders

2026-01-15
(Press-News.org)

Itaconate, an endogenous mitochondrial metabolite produced by the enzyme aconitate decarboxylase 1 (ACOD1), has emerged as a central regulator of inflammation, innate immunity, and cellular stress responses. In a comprehensive review published in the Journal of Intensive Medicine by Yang et al, researchers summarize the rapidly expanding field of itaconate biology—highlighting its chemical reactivity, protein modification mechanisms, and therapeutic potential across infectious, inflammatory, autoimmune, and neurodegenerative diseases.

Itaconate and its electrophilic derivatives, such as 4-octyl itaconate (4-OI) and dimethyl itaconate (DMI), exert their biological effects primarily through two types of post-translational modifications: cysteine-directed S-itaconation and lysine-targeted K-itaconation. S-itaconation occurs through Michael addition, enabling itaconate derivatives to covalently modify key inflammatory regulators—including KEAP1, STING1, JAK1, NLRP3, GSDMD, and TBK1. These modifications alter protein activity, disrupt protein–protein interactions, and reshape downstream signaling pathways, thereby limiting oxidative injury, inflammasome activation, antiviral signaling, and pyroptotic cell death. In contrast, K-itaconation is a reversible acylation event mediated by the intermediate itaconyl-CoA, which modifies multiple glycolytic enzymes and reprograms cellular metabolism toward an anti-inflammatory state.

“By integrating chemical biology, immunometabolism, and systems-level signaling, the review provides a mechanistic framework explaining how itaconate acts as a master regulator of macrophage activation. It suppresses glycolytic flux, inhibits succinate dehydrogenase, reduces mitochondrial respiration, and stabilizes the transcription factor NFE2L2 through KEAP1 modification. Collectively, these actions shift immune cells away from a pro-inflammatory phenotype and promote the resolution of inflammation,” mentions Dr. Yang.

The review also emphasizes the important distinction between endogenous itaconate and its more electrophilic derivatives. Endogenous itaconate can paradoxically amplify interferon signaling by promoting mitochondrial RNA release and activating MAVS-dependent antiviral pathways. In contrast, derivatives such as 4-OI predominantly suppress antiviral and inflammatory pathways through STING1 and JAK1 modification. This context-dependent duality underscores the need for careful interpretation when translating itaconate-based interventions.

Preclinical models demonstrate broad therapeutic potential for itaconate derivatives. In sepsis, 4-OI protects against lethal inflammation by inhibiting inflammasome activation, pyroptosis, and thrombosis. In inflammatory bowel disease, 4-OI blocks GSDMD- and GSDME-mediated cell death, preserving epithelial integrity and reducing colitis severity. In models of Alzheimer’s and Parkinson’s disease, itaconate derivatives attenuate microglial activation and oxidative stress by stabilizing NFE2L2, thereby improving neuronal survival and functional outcomes.

Furthermore, the review highlights emerging applications in autoimmunity and cancer. In systemic lupus erythematosus, 4-OI reduces type I interferon signatures and inflammatory cytokines. In rheumatoid arthritis, itaconate reprograms synovial fibroblast metabolism and suppresses invasive activity. In the tumor microenvironment, itaconate modulates dendritic-cell antigen presentation, immune-checkpoint stability, and tumor cell metabolism—revealing opportunities for combinatorial immunotherapy.

Technological advances, including chemoproteomic platforms such as ITalk, 1-OH-Az, and thermal proteome profiling, have accelerated the identification of itaconate-modified proteins, uncovering hundreds of modification sites across diverse pathways. These tools now enable precise mapping of S- and K-itaconation events and provide the foundation for developing targeted itaconate-based therapeutics.

The authors conclude that “itaconate biology represents a paradigm shift: redefining metabolic intermediates not as passive byproducts, but as active regulators of immune cell fate and inflammatory homeostasis. Continued discovery in this field is expected to yield new strategies for treating infectious diseases, sepsis, autoimmunity, neuroinflammation, and cancer”.

 

***

 

Reference
DOI: https://doi.org/10.1016/j.jointm.2025.10.002

END



ELSE PRESS RELEASES FROM THIS DATE:

Potential tumor-suppressing gene identified in pancreatic cancer

2026-01-15
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and begins in the cells lining the pancreatic duct. Accounting for more than 90% of all pancreatic cancers, PDAC is extremely difficult to treat and has a very high mortality rate. According to the Global Cancer Observatory 2022 report, pancreatic cancer is the sixth most common cancer in Japan, with over 47,000 new cases and more than 40,000 deaths, making it the fourth leading cause of cancer-related mortality in the country. In search of potential treatments, Ms. Mayuka Nii, a second-year doctoral ...

Winners of the 2026 Hill Prizes announced

2026-01-15
January 15, 2026 – Dallas – TAMEST (Texas Academy of Medicine, Engineering, Science and Technology) and Lyda Hill Philanthropies today announced the recipients of the 2026 Hill Prizes. The prizes, funded by Lyda Hill Philanthropies, propel high-risk, high-reward ideas and innovations that demonstrate significant potential for real-world impact and can lead to new, paradigm-shifting paths in research.   The prizes are given in seven categories: artificial intelligence, biological sciences, engineering, medicine, physical sciences, public health and technology. They recognize and advance top Texas innovators, providing seed funding to advance groundbreaking science and highlight ...

Autonomous AI agents developed to detect early signs of cognitive decline

2026-01-15
A team of Mass General Brigham researchers has developed one of the first fully autonomous artificial intelligence (AI) systems capable of screening for cognitive impairment using routine clinical documentation. The system, which requires no human intervention or prompting after deployment, achieved 98% specificity in real-world validation testing. Results are published in npj Digital Medicine. Alongside the publication, the team is releasing Pythia, an open-source tool that enables any healthcare system or research institution to deploy autonomous prompt optimization for their own AI screening applications. "We didn't build a single AI model — ...

Study finds ocean impacts nearly double economic cost of climate change

2026-01-15
For the first time, a study from researchers at Scripps Institution of Oceanography at the University of California San Diego integrates climate-related damages to the ocean into the social cost of carbon— a measure of economic harm caused by greenhouse gas emissions.  When ocean damage from climate change, dubbed the “blue” social cost of carbon, is calculated, the study finds that the global cost of carbon dioxide emissions to society nearly doubles. Until now, the ocean was largely overlooked in the standard accounting of the social cost ...

Increased deciduous tree dominance reduces wildfire carbon losses in boreal forests

2026-01-15
As climate change drives more frequent and severe wildfires across boreal forests in Alaska and northwestern Canada, scientists are asking a critical question: Will these ecosystems continue to store carbon or become a growing source of carbon emissions? New research published this week shows that when forests shift from coniferous—consisting mostly of pines, spruces and larches—to deciduous—consisting mostly of birches and aspens—they could release substantially less carbon when they burn. The National Science Foundation-funded study, led by researchers from the Center for Ecosystem Science and Society (ECOSS) at Northern Arizona University and published in ...

Researchers discover how a respiratory bacterium obtains essential lipids from the human body and targets fat-rich tissues

2026-01-15
Barcelona, January 15, 2026. A multidisciplinary team has uncovered a key mechanism that allows the human bacterium Mycoplasma pneumoniae—responsible for atypical pneumonia and other respiratory infections—to obtain cholesterol and other essential lipids directly from the human body. The discovery, published in Nature Communications, was co-led by Dr. Noemí Rotllan, from the Sant Pau Research Institute (IR Sant Pau) and the Center for Biomedical Research in Diabetes and Associated Metabolic Disorders (CIBERDEM); Dr. Marina Marcos, from the Autonomous University of Barcelona (UAB); and Dr. David Vizarraga, from the Institute of Molecular Biology ...

Locust swarms destroy crops. Scientists found a way to stop that

2026-01-15
“They’re very destructive when there's a lot of them, but one-on-one, what's not to love?” says Arianne Cease. She’s talking about locusts. As the director of Arizona State University’s Global Locust Initiative, Cease has a healthy admiration for these insects, even as she studies ways to manage locust swarms and prevent the destruction they cause. Locust swarms, which may conjure images of biblical plagues and ancient famines, remain a serious problem worldwide. They can destroy crops across entire regions, ruin people’s livelihoods, ...

More resources and collaboration needed to support prevention and treatment of obesity

2026-01-15
Statement Highlights: More than one-third of adults and children in the U.S. are living with obesity. Obesity rates are highest among non-Hispanic Black children and adults, low-income families, people living in rural areas and adults with a high school education or less. The latest research indicates that barriers to maintaining a healthy weight or participating in weight management programs include: limited access to healthy foods, lack of time to prepare meals and engage in regular physical activity, ...

Two types of underconfidence linked to anxiety and gender

2026-01-15
Women and people with anxiety are both prone to low confidence in their own abilities, but a new study by University College London (UCL) researchers has found that the two groups are prone to two distinct types of underconfidence. When they took more time to reflect on their answers in a simple experimental task, people with anxiety grew less confident in their answers, while women who were underconfident gained confidence. Lead author, Dr Sucharit Katyal, who completed the work as a postdoctoral researcher at the Max Planck UCL Centre ...

​​​​​​​Insects are victims too: Global study shows impacts of invasive alien species on populations

2026-01-15
Insects are often seen as invaders due to high-profile species like the yellow-legged (Asian) hornet, the harlequin ladybird and fire ant. but new research reveals insects are also major victims of invasive alien species – exacerbating population declines and reducing their ability to provide vital services for biodiversity and people from pollination to pest control. The first global analysis of its kind, led by the UK Centre for Ecology & Hydrology (UKCEH), revealed that invasive alien species reduce abundance of terrestrial insects* by 31% on average and reduce species richness by 21%. Invasive animals outcompete or eat insects while invasive vegetation replaces ...

LAST 30 PRESS RELEASES:

Study: Blocking a key protein may create novel form of stress in cancer cells and re-sensitize chemo-resistant tumors

HRT via skin is best treatment for low bone density in women whose periods have stopped due to anorexia or exercise, says study

Insilico Medicine showcases at WHX 2026: Connecting the Middle East with global partners to accelerate translational research

From rice fields to fresh air: Transforming agricultural waste into a shield against indoor pollution

University of Houston study offers potential new targets to identify, remediate dyslexia

Scientists uncover hidden role of microalgae in spreading antibiotic resistance in waterways

Turning orange waste into powerful water-cleaning material

Papadelis to lead new pediatric brain research center

Power of tiny molecular 'flycatcher' surprises through disorder

Before crisis strikes — smartwatch tracks triggers for opioid misuse

Statins do not cause the majority of side effects listed in package leaflets

UC Riverside doctoral student awarded prestigious DOE fellowship

UMD team finds E. coli, other pathogens in Potomac River after sewage spill

New vaccine platform promotes rare protective B cells

Apes share human ability to imagine

Major step toward a quantum-secure internet demonstrated over city-scale distance

Increasing toxicity trends impede progress in global pesticide reduction commitments

Methane jump wasn’t just emissions — the atmosphere (temporarily) stopped breaking it down

Flexible governance for biological data is needed to reduce AI’s biosecurity risks

Increasing pesticide toxicity threatens UN goal of global biodiversity protection by 2030

How “invisible” vaccine scaffolding boosts HIV immune response

Study reveals the extent of rare earthquakes in deep layer below Earth’s crust

Boston College scientists help explain why methane spiked in the early 2020s

Penn Nursing study identifies key predictors for chronic opioid use following surgery

KTU researcher’s study: Why Nobel Prize-level materials have yet to reach industry

Research spotlight: Interplay of hormonal contraceptive use, stress and cardiovascular risk in women

Pennington Biomedical’s Dr. Catherine Prater awarded postdoctoral fellowship from the American Heart Association

AI agents debate more effectively when given personalities and the ability to interrupt

Tenecteplase for acute non–large vessel occlusion 4.5 to 24 hours after ischemic stroke

Immune 'hijacking' predicts cancer evolution

[Press-News.org] Itaconate modifications: mechanisms and applications
Study uncovers dual roles of itaconate in controlling immune pathways, highlighting its potential for treating infection and inflammatory disorders